Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis

References

• Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1–17.
   PubMed Web of Science ®Google Scholar
• Anderson BO, Braun S, Lim S, et al. Early detection of breast cancer in countries with limited resources. Breast J. 2003;9(Suppl 2):S51–59.
   PubMedGoogle Scholar
• Maughan KL, Lutterbie MA, Ham PS. Treatment of breast cancer. Am Fam Physician. 2010;81(11):1339–1346.
   PubMed Web of Science ®Google Scholar
• Mahvi DA, Liu R, Grinstaff MW, et al. Local cancer recurrence: the realities, challenges, and opportunities for new therapies. CA Cancer J Clin. 2018;68(6):488–505.
   PubMed Web of Science ®Google Scholar
• DeSantis C, Ma J, Bryan L, et al. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52–62.
   PubMed Web of Science ®Google Scholar
• Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51–64.
   PubMed Web of Science ®Google Scholar
• Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem. 2014;9(9):1932–1956.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang P, Sun H, et al. LINC01094/miR-577 axis regulates the progression of ovarian cancer. J Ovarian Res. 2020;13(1):122.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li W, Yan Y, et al. LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis. Cancer Cell Int. 2020;20(1):274.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhang H, Li W, et al. FOXM1-activated LINC01094 promotes clear cell renal cell carcinoma development via microRNA 224-5p/CHSY1. Mol Cell Biol. 2020;40(3):3.
   Web of Science ®Google Scholar
• Liu W, Mao SY, Zhu WY. Impact of tiny miRNAs on cancers. World J Gastroenterol. 2007;13(4):497–502.
   PubMed Web of Science ®Google Scholar
• Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23(1):175–205.
   PubMed Web of Science ®Google Scholar
• Yu Y, He Y, Shao Y, et al. lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR‑340‑5p‑dependent upregulation of SOX4. Oncol Rep. 2020;44(4):1511–1523.
   PubMed Web of Science ®Google Scholar
• Tan PY, Wen LJ, Li HN, et al. MiR-548c-3p inhibits the proliferation, migration and invasion of human breast cancer cell by targeting E2F3. Cytotechnology. 2020;72(5):751–761.
   PubMed Web of Science ®Google Scholar
• Peters CH, Myers ME, Juchno J, et al. Isoform-specific regulation of HCN4 channels by a family of endoplasmic reticulum proteins. Proc Natl Acad Sci U S A. 2020;117(30):18079–18090.
   PubMed Web of Science ®Google Scholar
• Cheng Y-C, Su L-Y, Chen L-H, et al. functional roles of hypoxia-induced long non-coding RNA in breast cancer cells. Front Oncol. 2021;11:663114.
   PubMed Web of Science ®Google Scholar
• Wang H, Jiao H, Jiang Z, et al. Propofol inhibits migration and induces apoptosis of pancreatic cancer PANC-1 cells through miR-34a-mediated E-cadherin and LOC285194 signals. Bioengineered. 2020;11(1):510–521.
   PubMed Web of Science ®Google Scholar
• Wang J-F, Zhao K, Chen -Y-Y, et al. NKCC1 promotes proliferation, invasion and migration in human gastric cancer cells via activation of the MAPK-JNK/EMT signaling pathway. J Cancer. 2021;12(1):253–263.
   PubMed Web of Science ®Google Scholar
• Chen S, Xu H, Hu F, et al. Identification of key players involved in cocl hypoxia induced pulmonary artery hypertension. Front Genet. 2020;11:232.
   PubMed Web of Science ®Google Scholar
• Yuan S, Peng L, Park JJ, et al. Nonstructural protein 1 of sars-cov-2 is a potent pathogenicity factor redirecting host protein synthesis machinery toward viral RNA. Mol Cell. 2020;80(6):6.
   PubMed Web of Science ®Google Scholar
• Akhavan D, Pourzia AL, Nourian AA, et al. De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients. Cancer Discov. 2013;3(5):534–547.
   PubMed Web of Science ®Google Scholar
• Zhang L, Cheng H, Yue Y, et al. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells. J Biomed Sci. 2018;25(1):11.
   PubMed Web of Science ®Google Scholar
• Arenhart RA, Bai Y, de Oliveira LFV, et al. New insights into aluminum tolerance in rice: the ASR5 protein binds the STAR1 promoter and other aluminum-responsive genes. Mol Plant. 2014;7(4):709–721.
   PubMed Web of Science ®Google Scholar
• Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719.
   PubMed Web of Science ®Google Scholar
• Brunner AL, Beck AH, Edris B, et al. Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol. 2012;13(8):R75.
   PubMed Web of Science ®Google Scholar
• Wang S, Liang K, Hu Q, et al. JAK2-binding long noncoding RNA promotes breast cancer brain metastasis. J Clin Invest. 2017;127(12):4498–4515.
   PubMed Web of Science ®Google Scholar
• Arora S, Chaudhary B. Global expression dynamics and miRNA evolution profile govern floral/fiber architecture in the modern cotton (Gossypium). Planta. 2021 Aug 30;254(3):62.
   PubMed Web of Science ®Google Scholar
• Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20(8):460–469.
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Jana S, Chatterjee S, et al. MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer. Br J Cancer. 2019;121(8):679–689.
   PubMed Web of Science ®Google Scholar
• Jinghua H, Qinghua Z, Chenchen C, et al. MicroRNA miR-92a-3p regulates breast cancer cell proliferation and metastasis via regulating B-cell translocation gene 2 (BTG2). Bioengineered. 2021;12(1):2033–2044.
   PubMed Web of Science ®Google Scholar
• Cheng B, Rong A, Zhou Q, et al. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway. J Exp Clin Cancer Res. 2020;39(1):5.
   PubMed Web of Science ®Google Scholar
• Yang MD, Chen XL, Hu XQ, et al. Traditional Chinese medicine syndromes distribution in colorectal cancer and its association with western medicine treatment and clinical laboratory indicators. World J Chin Med. 2019. 51:81–87
   Google Scholar
• Meng L, Yue X, Zhou D, et al. Long non coding RNA OIP5‑AS1 promotes metastasis of breast cancer via miR‑340‑5p/ZEB2 axis. Oncol Rep. 2020;44(4):1662–1670.
   PubMed Web of Science ®Google Scholar
• Wu L, Timmers C, Maiti B, et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001;414(6862):457–462.
   PubMed Web of Science ®Google Scholar
• Humbert PO, Verona R, Trimarchi JM, et al. E2f3 is critical for normal cellular proliferation. Genes Dev. 2000;14(6):690–703.
   PubMed Web of Science ®Google Scholar
• Santos M, Martínez-Fernández M, Dueñas M, et al. In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer. Cancer Res. 2014;74(22):6565–6577.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yasui W, Yokozaki H, et al. Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer. 1999;81(4):535–538.
   PubMed Web of Science ®Google Scholar
• Huang CL, Liu D, Nakano J, et al. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2007;13(23):6938–6946.
   PubMed Web of Science ®Google Scholar
• He X, Chai P, Li F, et al. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3. Mol Cancer. 2020;19(1):115.
   PubMed Web of Science ®Google Scholar
• Olsson AY, Feber A, Edwards S, et al. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene. 2007;26(7):1028–1037.
   PubMed Web of Science ®Google Scholar
• Trikha P, Sharma N, Pena C, et al. E2f3 in tumor macrophages promotes lung metastasis. Oncogene. 2016;35(28):3636–3646.
   PubMed Web of Science ®Google Scholar
• Grasemann C, Gratias S, Stephan H, et al. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene. 2005;24(42):6441–6449.
   PubMed Web of Science ®Google Scholar
• Pei Y, Tang Z, Cai M, et al. The E2F3/miR-125a/DKK3 regulatory axis promotes the development and progression of gastric cancer. Cancer Cell Int. 2019;19(1):212.
   PubMed Web of Science ®Google Scholar
• Wan J, Liu H, Feng Q, et al. HOXB9 promotes endometrial cancer progression by targeting E2F3. Cell Death Dis. 2018;9(5):509.
   PubMedGoogle Scholar
• Han R, Zhao J, Lu L. MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression. Oncol Rep. 2020;43(6):2062–2072.
   PubMed Web of Science ®Google Scholar